摘要
目的分析阿维A联合雷公藤多甙治疗银屑病的效果。方法将银屑病患者86例分为两组,对照组行阿维A治疗,观察组加用雷公藤多甙,比较两组治疗效果。结果观察组治疗总有效率为93.0%,高于对照组的76.7%,治疗后观察组CD3+、CD4+与CD4+/CD8+水平均高于对照组(P<0.05)。两组不良反应差异无统计学意义(P>0.05)。结论阿维A联合雷公藤多甙对银屑病有显著疗效。
Objective To analyze the effect of acitretin combined with tripterygium glycosides in treatment of psoriasis. Methods 86 cases of patients with psoriasis were divided into two groups,the control group underwent acitretin treatment,observation group were treated with acitretin and tripterygium glycosides,the treatment effect of two groups were compared. Results The total effective rate of observation group's 93.0% was significantly higher than that of control group's 76.7%. After treatment,CD3^+、CD4^+ and CD4^+/CD8^+ in the observation group were higher than that in the control group(P〈0.05). There was no significant difference in adverse reactions between the two groups(P〈0.05).Conclusion Acitretin combined with tripterygium glycosides has obvious therapeutic effect on psoriasis.
出处
《中国卫生标准管理》
2016年第22期131-133,共3页
China Health Standard Management
关键词
银屑病
阿维A
雷公藤多甙
免疫功能
Psoriasis
Avermectin
Tripterygium glycosides
Immune function